Gabriel J Culbert1, Agung Waluyo2, Mariska Iriyanti2, Azalia P Muchransyah2, Adeeba Kamarulzaman3, Frederick L Altice4. 1. Yale University School of Medicine, Section of Infectious Diseases, AIDS Program, New Haven, CT, USA; Universitas Indonesia, Faculty of Nursing, Center for HIV/AIDS Nursing Research, Depok, Indonesia; University of Malaya, Faculty of Medicine, Centre of Excellence for Research in AIDS (CERiA), Kuala Lumpur, Malaysia. Electronic address: gabriel.culbert@yale.edu. 2. Universitas Indonesia, Faculty of Nursing, Center for HIV/AIDS Nursing Research, Depok, Indonesia. 3. University of Malaya, Faculty of Medicine, Centre of Excellence for Research in AIDS (CERiA), Kuala Lumpur, Malaysia. 4. Yale University School of Medicine, Section of Infectious Diseases, AIDS Program, New Haven, CT, USA; Yale University School of Public Health, Division of Epidemiology of Microbial Diseases, New Haven, CT, USA; University of Malaya, Faculty of Medicine, Centre of Excellence for Research in AIDS (CERiA), Kuala Lumpur, Malaysia.
Abstract
BACKGROUND: In Indonesia, incarceration of people who inject drugs (PWID) and access to drugs in prison potentiate within-prison drug injection (WP-DI), a preventable and extremely high-risk behavior that may contribute substantially to HIV transmission in prison and communities to which prisoners are released. AIMS: This mixed method study examined the prevalence, correlates, and social context of WP-DI among HIV-infected male prisoners in Indonesia. METHODS: 102 randomly selected HIV-infected male prisoners completed semi-structured voice-recorded interviews about drug use changes after arrest, drug use cues within prison, and impact of WP-DI on HIV and addiction treatment. Logistic regression identified multivariate correlates of WP-DI and thematic analysis of interview transcripts used grounded-theory. RESULTS: Over half (56%) of participants reported previous WP-DI. Of those, 93% shared injection equipment in prison, and 78.6% estimated sharing needles with ≥ 10 other prisoners. Multivariate analyses independently correlated WP-DI with being incarcerated for drug offenses (AOR = 3.29, 95%CI = 1.30-8.31, p = 0.011) and daily drug injection before arrest (AOR = 5.23, 95%CI = 1.42-19.25, p = 0.013). Drug availability and proximity to drug users while incarcerated were associated with frequent drug craving and escalating drug use risk behaviors after arrest. Energetic heroin marketing and stigmatizing attitudes toward methadone contribute to WP-DI and impede addiction and HIV treatment. CONCLUSIONS: Frequent WP-DI and needle sharing among these HIV-infected Indonesian prison inmates indicate the need for structural interventions that reduce overcrowding, drug supply, and needle sharing, and improve detection and treatment of substance use disorders upon incarceration to minimize WP-DI and associated harm.
BACKGROUND: In Indonesia, incarceration of people who inject drugs (PWID) and access to drugs in prison potentiate within-prison drug injection (WP-DI), a preventable and extremely high-risk behavior that may contribute substantially to HIV transmission in prison and communities to which prisoners are released. AIMS: This mixed method study examined the prevalence, correlates, and social context of WP-DI among HIV-infected male prisoners in Indonesia. METHODS: 102 randomly selected HIV-infected male prisoners completed semi-structured voice-recorded interviews about drug use changes after arrest, drug use cues within prison, and impact of WP-DI on HIV and addiction treatment. Logistic regression identified multivariate correlates of WP-DI and thematic analysis of interview transcripts used grounded-theory. RESULTS: Over half (56%) of participants reported previous WP-DI. Of those, 93% shared injection equipment in prison, and 78.6% estimated sharing needles with ≥ 10 other prisoners. Multivariate analyses independently correlated WP-DI with being incarcerated for drug offenses (AOR = 3.29, 95%CI = 1.30-8.31, p = 0.011) and daily drug injection before arrest (AOR = 5.23, 95%CI = 1.42-19.25, p = 0.013). Drug availability and proximity to drug users while incarcerated were associated with frequent drug craving and escalating drug use risk behaviors after arrest. Energetic heroin marketing and stigmatizing attitudes toward methadone contribute to WP-DI and impede addiction and HIV treatment. CONCLUSIONS: Frequent WP-DI and needle sharing among these HIV-infected Indonesian prison inmates indicate the need for structural interventions that reduce overcrowding, drug supply, and needle sharing, and improve detection and treatment of substance use disorders upon incarceration to minimize WP-DI and associated harm.
Authors: Sasha Uhlmann; M-J Milloy; Thomas Kerr; Ruth Zhang; Silvia Guillemi; David Marsh; Robert S Hogg; Julio S G Montaner; Evan Wood Journal: Addiction Date: 2010-03-10 Impact factor: 6.526
Authors: Gerry V Stimson; Chris Fitch; Don DesJarlais; Vladimir Poznyak; Theresa Perlis; Edna Oppenheimer; Tim Rhodes Journal: Am J Public Health Date: 2005-12-27 Impact factor: 9.308
Authors: Will Small; S Kain; Nancy Laliberte; Martin T Schechter; Michael V O'Shaughnessy; Patricia M Spittal Journal: Subst Use Misuse Date: 2005 Impact factor: 2.164
Authors: Evan Wood; Kathy Li; Will Small; Julio S Montaner; Martin T Schechter; Thomas Kerr Journal: Public Health Rep Date: 2005 Mar-Apr Impact factor: 2.792
Authors: W L Holzemer; S B Henry; K M Nokes; I B Corless; M A Brown; G M Powell-Cope; J G Turner; J Inouye Journal: J Adv Nurs Date: 1999-11 Impact factor: 3.187
Authors: Joost J G Wammes; Adiatma Y Siregar; Teddy Hidayat; Reynie P Raya; Reinout van Crevel; André J van der Ven; Rob Baltussen Journal: Int J Drug Policy Date: 2012-08-10
Authors: Robin A Pollini; Jorge Alvelais; Manuel Gallardo; Alicia Vera; Remedios Lozada; Carlos Magis-Rodriquez; Steffanie A Strathdee Journal: Drug Alcohol Depend Date: 2009-04-21 Impact factor: 4.492
Authors: Gabriel J Culbert; Alexander R Bazazi; Agung Waluyo; Astia Murni; Azalia P Muchransyah; Mariska Iriyanti; Maxim Polonsky; Judith Levy; Frederick L Altice Journal: AIDS Behav Date: 2016-05
Authors: Gabriel J Culbert; Valerie A Earnshaw; Ni Made Swasti Wulanyani; Martin P Wegman; Agung Waluyo; Frederick L Altice Journal: J Assoc Nurses AIDS Care Date: 2015-07-31 Impact factor: 1.354
Authors: Gabriel J Culbert; Veena Pillai; Joseph Bick; Haider A Al-Darraji; Jeffrey A Wickersham; Martin P Wegman; Alexander R Bazazi; Enrico Ferro; Michael Copenhaver; Adeeba Kamarulzaman; Frederick L Altice Journal: J Neuroimmune Pharmacol Date: 2016-05-24 Impact factor: 4.147
Authors: Lyuba Azbel; Martin P Wegman; Maxim Polonsky; Chethan Bachireddy; Jaimie Meyer; Natalya Shumskaya; Ainura Kurmanalieva; Sergey Dvoryak; Frederick L Altice Journal: Int J Prison Health Date: 2018-09-10
Authors: Joanne Csete; Adeeba Kamarulzaman; Michel Kazatchkine; Frederick Altice; Marek Balicki; Julia Buxton; Javier Cepeda; Megan Comfort; Eric Goosby; João Goulão; Carl Hart; Thomas Kerr; Alejandro Madrazo Lajous; Stephen Lewis; Natasha Martin; Daniel Mejía; Adriana Camacho; David Mathieson; Isidore Obot; Adeolu Ogunrombi; Susan Sherman; Jack Stone; Nandini Vallath; Peter Vickerman; Tomáš Zábranský; Chris Beyrer Journal: Lancet Date: 2016-03-24 Impact factor: 79.321
Authors: Frederick L Altice; Lyuba Azbel; Jack Stone; Ellen Brooks-Pollock; Pavlo Smyrnov; Sergii Dvoriak; Faye S Taxman; Nabila El-Bassel; Natasha K Martin; Robert Booth; Heino Stöver; Kate Dolan; Peter Vickerman Journal: Lancet Date: 2016-07-14 Impact factor: 79.321